Research Feeds

View All
Characterizing the gut microbiota in females with infertility and preliminary results of a water-soluble dietary fiber intervention study A prebiotic dietary pilot intervention restores faecal metabolites and may be neuroprotective in Parkinson’s Disease Diagnosis of the menopause: NICE guidance and quality standards Causes of Death in End-Stage Kidney Disease: Comparison Between the United States Renal Data System and a Large Integrated Health Care System Factors affecting the absorption and excretion of lead in the rat Factors associated with age at menarche, menstrual knowledge, and hygiene practices among schoolgirls in Sharjah, UAE Cadmium transport in blood serum The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic Structured Exercise Benefits in Euthyroid Graves’ Disease: Improved Capacity, Fatigue, and Relapse Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease A Pilot Microbiota Study in Parkinson’s Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models Dysbiosis of the Saliva Microbiome in Patients With Polycystic Ovary Syndrome Integrated Microbiome and Host Transcriptome Profiles Link Parkinson’s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain Gut microbiota modulation: a narrative review on a novel strategy for prevention and alleviation of ovarian aging Long-term postmenopausal hormone therapy and endometrial cancer

Role of Nickel in Microbial Pathogenesis Original paper

Researched by:

  • Karen Pendergrass ID
    Karen Pendergrass

    User avatarKaren Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

    Read More
  • Dr. Umar ID
    Dr. Umar

    User avatarClinical Pharmacist and Clinical Pharmacy Master’s candidate focused on antibiotic stewardship, AI-driven pharmacy practice, and research that strengthens safe and effective medication use. Experience spans digital health research with Bloomsbury Health (London), pharmacovigilance in patient support programs, and behavioral approaches to mental health care. Published work includes studies on antibiotic use and awareness, AI applications in medicine, postpartum depression management, and patient safety reporting. Developer of an AI-based clinical decision support system designed to enhance antimicrobial stewardship and optimize therapeutic outcomes.

    Read More

November 27, 2025

  • Metals
    Metals

    Heavy metals play a significant and multifaceted role in the pathogenicity of microbial species.

Researched by:

  • Karen Pendergrass ID
    Karen Pendergrass

    User avatarKaren Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

    Read More
  • Dr. Umar ID
    Dr. Umar

    User avatarClinical Pharmacist and Clinical Pharmacy Master’s candidate focused on antibiotic stewardship, AI-driven pharmacy practice, and research that strengthens safe and effective medication use. Experience spans digital health research with Bloomsbury Health (London), pharmacovigilance in patient support programs, and behavioral approaches to mental health care. Published work includes studies on antibiotic use and awareness, AI applications in medicine, postpartum depression management, and patient safety reporting. Developer of an AI-based clinical decision support system designed to enhance antimicrobial stewardship and optimize therapeutic outcomes.

    Read More

Last Updated: 2025-05-03

Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.

Karen Pendergrass

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

What was reviewed?

This review examined nickel in microbial pathogenesis, focusing on how nickel-dependent enzymes shape virulence across bacteria, fungi, and select protozoa. Nickel in microbial pathogenesis emerges as a central theme because pathogens rely heavily on nickel-requiring enzymes—particularly urease and [NiFe]-hydrogenases—to survive hostile host environments, acquire nutrients, and drive energy metabolism. Using mechanistic, genomic, and in vivo evidence, the paper synthesizes findings across more than forty prokaryotic and nine eukaryotic pathogens, emphasizing how nickel scarcity within the host constrains microbial physiology and selects for specialized uptake, storage, and trafficking systems. The review also integrates structural insights, host nutritional immunity, and emerging metallophore pathways, illustrating how nickel availability shapes pathogenic strategies and may represent a therapeutic vulnerability.

Who was reviewed?

The review covered a wide spectrum of microbial taxa, including gastric Helicobacter species, enteric bacteria such as Salmonella and Shigella, uropathogens like Proteus, Klebsiella, and Staphylococcus species, as well as fungal pathogens including Cryptococcus and Coccidioides. These organisms possess nickel-requiring enzymes used for acid resistance, nitrogen acquisition, energy generation, oxidative stress defense, or metabolic detoxification. Some protozoan parasites—including Leishmania and Trypanosoma—were discussed for their nickel-dependent glyoxalase systems. The organisms reviewed represent pathogens inhabiting diverse niches such as the stomach, urinary tract, respiratory tract, bloodstream, skin, macrophages, and central nervous system, with nickel biochemistry serving as a shared determinant of successful host colonization.

Most important findings

Nickel-dependent urease and [NiFe]-hydrogenases are the most influential virulence factors. Urease enables pathogens like Helicobacter pylori, Proteus mirabilis, and Cryptococcus neoformans to neutralize acidic environments through ammonia production; in urinary pathogens, this activity drives stone formation and biofilm-associated persistence. In H. pylori, urease also performs noncatalytic antioxidant functions tied to methionine-sulfoxide cycling. Hydrogenases fuel pathogenic energy metabolism: H. pylori uses hydrogen to power CO₂ fixation and energize CagA oncoprotein delivery. Enteric pathogens like Salmonella Typhimurium require multiple hydrogenases for gut colonization and intracellular survival. Additional nickel enzymes—Ni-glyoxalase I, Ni-superoxide dismutase, and Ni-acireductone dioxygenase—contribute to methylglyoxal detoxification, oxidative stress defense, and methionine salvage. A major theme is host-driven nickel limitation via calprotectin, lactoferrin, and hepcidin, which pressures pathogens to evolve high-affinity uptake systems (NikABCDE, NixA, NiCoT), metallophores such as staphylopine and pseudopaline, and histidine-rich storage proteins (Hpn, Hpnl) that buffer nickel and coordinate enzyme maturation. This interplay between host nutritional immunity and pathogen nickel acquisition emerges as a defining microbiome-relevant axis.

Nickel-associated factorMicrobiome-relevant pathogenic impact
Urease (e.g., H. pylori, P. mirabilis)Acid neutralization, ammonia-driven dysbiosis, stone formation supporting polymicrobial biofilms
[NiFe]-Hydrogenases (e.g., H. pylori, Salmonella)Hydrogen-dependent energy metabolism enhancing colonization, intracellular survival, and toxin delivery
Nickel uptake and metallophore systemsCompetitive advantage within the microbiome through enhanced metal scavenging and enzyme activation
Nickel-storage proteins (Hpn, Hpnl)Stabilization of enzyme maturation under metal scarcity, supporting long-term persistence in mucosal niches

Key implications

The review highlights nickel as a crucial microbial resource absent from mammalian biochemistry—creating an exploitable therapeutic gap. Targeting nickel uptake or storage could cripple multiple virulence pathways simultaneously, especially in pathogens highly dependent on urease and hydrogenase activity. Because commensal microbiota also use nickel enzymes, the review underscores the need for microbiome-aware therapeutic design. Nickel availability may shape microbial community structure, pathogen competition, and disease susceptibility. Understanding nickel-dependent signatures could enhance microbiome profiling, pathogen detection, and biomarker discovery.

Citation

Maier RJ, Benoit SL. Role of nickel in microbial pathogenesis. Inorganics. 2019;7(7):80. inorganics-07-00080

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.